| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8218074 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 9 Pages |
Abstract
Both intrafraction and residual interfraction prostate motion degrade CTV coverage within a clinically acceptable level. One-field-per-day SFUD delivered twice is as robust as the bilateral SFUD plan treated daily over the course of treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shikui PhD, Curtiland MD, Zelig MD, Ken Kang-Hsin PhD, James PhD, Neha MD, Stefan PhD,